Clume Health Tirzepatide Review: $259/Month, Oral or Injectable (2026)

Clume Health charges $259 a month, month to month, for full-dose tirzepatide, and the identical $259 buys full-dose semaglutide in either an oral or an injectable form, so the molecule is a clinical decision rather than a budget one. The figure sits on the program page before the intake asks anything, read live on 1 September 2026.¹

What $259 covers, and what the cheaper numbers cost you

The inclusion list puts the treatment plan, the consultation and ongoing oversight, the medication and delivery inside that one figure, and no membership or shipping fee appears anywhere. Two smaller numbers share the same cards, and both are commitments rather than rates. A rate of $186 a month requires a 52-week plan, a year bought up front, while $200 a month belongs to the microdose and maintenance track whose standing rate is $219. A reader scanning either card sees two monthly figures side by side, separated only by that qualifier.

The two homepage figures that match nothing Clume sells

The homepage advertises GLP-1 and microdose programs starting at $199 a month and cellular optimization at $159, but the page that actually prices them shows floors of $259, $219 and $216. Each hero figure carries an asterisk that resolves to nothing: a census on 1 September found no footnote text on the page.

Four pharmacies named, and a designation nobody states

The Terms of Use list four dispensing pharmacies outright, each with a street address and a phone number: RedRock Pharmacy, Health Warehouse, Precision Medicine and Triad Rx. That is a real disclosure, and it stops short twice. The Terms never say which pharmacy fills which program, and they reserve the right to move a prescription among the four for availability, pricing or operational reasons. A census of the homepage, the program page and the three legal pages found no instance of 503A, 503B or NPI, and no clinician is named.

The brand-vs-compounded question

Clume sells no brand product, and it never says outright that its tirzepatide is compounded. The word compounding occurs once, inside the Terms' definition of a pharmacy. A compounded drug is made by a pharmacy, holds no FDA approval as a finished product, and is not what the pivotal trials measured — our guide to whether compounded tirzepatide is still legal in 2026 sets out where that stands.

How the care model holds up

The strengths are a price readable before you commit and a refund if a clinician disqualifies you. The paperwork is thinner. The refund policy describes a bundled price including a 24/7 patient support line, while no Clume phone number exists anywhere and support runs by email. Cancellation needs 72 hours' notice before the next billing date, the month you cancel in is not refunded, and a prepaid plan is refunded only for months in which nothing shipped.

Does the drug work? (Separate from the provider)

Judge the seller on what it publishes and how it bills; judge the molecule on its trials. Tirzepatide's are strong — roughly 15% to 21% of body weight over 72 weeks in SURMOUNT-1², and ahead of semaglutide head to head in SURMOUNT-5³ — though both trials used the brand product. Our tirzepatide evidence guide has the full picture.

The honest verdict

Clume is easy to price and hard to place. One figure covering two molecules and two routes helps anyone weighing the clinical question apart from the money. A homepage advertising $199 for programs that start at $259 should be fixed rather than footnoted. Lean Meds charges $109 a month and names its four pharmacies as 503A facilities, which is the one line Clume leaves blank, and Collective splits its bill rather than bundling it, at $69 a month for the medication and $199 a year for the membership that unlocks it. The ranked best tirzepatide providers list sets all three against the field.